News
News releases on April 10, 2021
Every news release public companies put out on April 10, 2021 (UTC): 19 news releases, newest first. Open any release to read it.
Global Tech Industries Group, Inc. signs letter of intent with alt 5 Sigma, Inc. to explore business combination
Global Tech Industries Group, Inc. · Apr 10, 2021
Else Nutrition Issues Shares for Services
Else Nutrition Holdings Inc · Apr 10, 2021
Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its WEE1 Inhibitor, in P...
Zentalis Pharmaceuticals, Inc. · Apr 10, 2021
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021
Xencor, Inc. · Apr 10, 2021
Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Can...
Scholar Rock Holding Corporation · Apr 10, 2021
Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1B...
Palvella Therapeutics, Inc. · Apr 10, 2021
Phio Pharmaceuticals Presents Positive In Vivo Data Showing Strong Tumor Control for the Intratumoral Delivery of INTASYL™ RNAi Targeting...
Phio Pharmaceuticals Corp. · Apr 10, 2021
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
MacroGenics, Inc. · Apr 10, 2021
Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-4...
Kymera Therapeutics, Inc. · Apr 10, 2021
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual ...
Kezar Life Sciences, Inc. · Apr 10, 2021
iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication
iRhythm Holdings, Inc. · Apr 10, 2021
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of G...
Greenwich LifeSciences, Inc. · Apr 10, 2021
CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function
CRISPR Therapeutics AG · Apr 10, 2021
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR...
C4 Therapeutics, Inc. · Apr 10, 2021
Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC...
Bolt Biotherapeutics, Inc. · Apr 10, 2021
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research...
Black Diamond Therapeutics, Inc. · Apr 10, 2021
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients
Biodesix, Inc. · Apr 10, 2021
Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppress...
Allogene Therapeutics, Inc. · Apr 10, 2021
Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates
Hemostemix Inc · Apr 10, 2021